Today, researcher Harry Ashpitel presented his Varicose veins laser research. This presentation was to the American Venous Forum in New Orleans, USA.
The American Venous Forum is one of the premier scientific societies for research into varicose veins and venous disease in the world.
Harry is currently a PhD student at The Whiteley Clinic and University of Surrey.
Prof Mark Whiteley leads the research team and gives the researchers their projects. He also supervises the clinical side of the research.
The close working relationship that The Whiteley Clinic has University of Surrey enables researchers to use some of the very latest techniques available in science.
Harry’s project has been to look at the effects of endovenous laser ablation on varicose veins.
The National Institute of Health and Clinical excellence has recommended that varicose veins are best treated by “endothermal ablation”. This guideline is known as NICE clinical guidelines CG 168. The so-called “endothermal ablation” really means endovenous laser ablation or endovenous radiofrequency ablation.
Mark Whiteley introduced this into the UK, performing the first such case on 12 March 1999. Initially, he used radiofrequency ablation then swapped to endovenous laser ablation is this appears to have advantages when performed under local anaesthetic.
Ever since 1999, has been leading research into how to treat varicose veins better. He and his team many peer-reviewed publications and prizes relating to this subject.
This current project is looking at the difference between laser close along and laser files directly into the vein wall. Both techniques are currently used and both are called “endovenous laser ablation”. Most of the public do not know the different lasers can be used with different wavelengths and different fibre tips.
However, results from varicose veins laser treatment depend very much on which techniques and devices used in combination.
It is because The Whiteley Clinic performs such research, and they feed this back into their famous Whiteley Protocol, that they are able to continue to have the lowest recurrence rates possible after varicose veins treatment.